For how we live.
Every article we have published on Global Health Financing, newest first.
A run of CDC sole-source awards in August 2026 sends millions directly to the health ministries of Ethiopia, Zambia and Ukraine — a bet on host-government ownership of the HIV response by 2030.
The prequalification is about delivery, not efficacy: a cheaper, multi-dose presentation of RSVpreF meant to make large-scale rollout feasible where almost all RSV deaths occur.
The Gates Foundation has committed to a decade of funding for the world's most-used health estimates. Science reports the criticism that has followed the study for years: opacity.
Developing countries paid a record US$1.4 trillion in debt service in 2023. A 105-country study finds debt servicing nudges the health-financing mix toward out-of-pocket, but only modestly.
The FY2027 request would cut global health funding by $4.3 billion and eliminate WHO, PAHO and UNFPA outright. Three weeks later House appropriators proposed a smaller cut.
The estimate covers 2000 to 2023 and 108 countries. It is a counterfactual model, not a measured saving, and it lands as the US and other donors debate cutting the disease-specific funding it credits.
Sub-Saharan Africa received $11 billion in external assistance for community health worker programmes over two decades. More than three-quarters went to single-disease work, and the annual financing gap never closed.
The Eighth Replenishment closed at US$12.64 billion against the US$18 billion its own Investment Case tied to 23 million lives saved and 400 million infections prevented by 2029.
The Lancet Global Health paper that produced this month's headline number also produced a larger one: 22.6 million additional deaths by 2030 if defunding deepens. The distinction matters more than the figure.
Washington intends to provide up to $792 million over five years. Malawi commits the rest — and the money is meant to flow through the government rather than NGOs.
WHO's World malaria report counts 282 million cases and 610,000 deaths for 2024. The US$3.9 billion spent was under half the US$9.3 billion the global strategy called for.
The modelling study puts 719,384 people on PEPFAR-funded oral PrEP in 28 African countries at the end of 2024. Most projected infections fall on key populations whose coverage was already under 6%.
IHME's annual accounting puts development assistance for health at less than half its 2021 peak, with no recovery forecast to 2030. A companion model estimates what that means for tuberculosis.
The World Health Assembly approved US$6.2 billion for 2026-2027 after trimming the base to US$4.27 billion. The notified US withdrawal cut the assessments available for it by US$311.1 million.